Clinical Trials
Second study of small molecule organic arsenic in solid tumors underway
Published in Medical Letter on the CDC and FDA, July 3rd, 2005
This trial is being conducted in up to 40 patients with diverse solid tumors and complements the recently initiated phase 1 study in patients with hematological malignancies.
The principle investigator for this single center trial is Dr. Luis H. Camacho at The University of Texas M. D. Anderson Cancer Center. ZIO-101 is the first molecule from a family of novel organic arsenics. The company's investigational new drug application was initially approved by the Food and Drug...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Arthritis
Trends in total knee replacements implicate osteoarthritis and obesity - Breast Pumps
Adverse events linked to breast pumps - HIV Vaccine
Sexual risk behavior is high among vaccine efficacy trial subjects - Hodgkin Lymphoma
Interleukin-4 cytotoxin may be a unique agent against Hodgkin lymphoma - Lead Poisoning
CDC issues recommendations for newly arrived refugee children - Acute Radiation Syndrome
New drug being developed for the treatment of acute radiation syndrome - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
